Scott R. Ward - 05 Aug 2022 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Chairman and CEO, Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Scott R. Ward pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 05 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Aug 2022, 16:24:36 UTC
Previous filing: 23 May 2022
Next filing: 16 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Award	$0	+79,940	+14%	$0.000000	660,653	05 Aug 2022	Direct	F1
transaction	CSII	Common Stock	Award	$0	+239,819	+36%	$0.000000	900,472	05 Aug 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CSII	Restricted Stock Units						34,297	05 Aug 2022	Common Stock	34,297		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restrictions lapse as to 26,647 shares on each of 8/13/23 and 8/13/24 and as to 26,646 shares on 8/13/25.
F2	Subject to performance-based forfeiture of 119,910 shares based on the Company's three-year total shareholder return for fiscal years 2023, 2024 and 2025 versus the Company's peer group, and for 119,909 shares based on the Company's average annual revenue growth in fiscal years 2023, 2024 and 2025.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of the Company's common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.